118
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Influence of olanzapine on serum prolactin levels and BMI in female patients with schizophrenia

, , , , , , & show all
Pages 3373-3379 | Published online: 13 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Carlo Rossi, Nicole Campese & Carlo Colosimo. (2023) Emerging Symptomatic Treatment of Chronic Traumatic Encephalopathy (CTE): a narrative review. Expert Opinion on Pharmacotherapy 24:13, pages 1415-1425.
Read now

Articles from other publishers (5)

Xiaoni Guan, Jing Xu, Meihong Xiu, Xirong Li, Haixia Liu & Fengchun Wu. (2022) Kynurenine pathway metabolites and therapeutic response to olanzapine in female patients with schizophrenia: A longitudinal study. CNS Neuroscience & Therapeutics 28:10, pages 1539-1546.
Crossref
Peter Phiri, Tomas Engelthaler, Hannah Carr, Gayathri Delanerolle, Clive Holmes & Shanaya Rathod. (2022) Associated mortality risk of atypical antipsychotic medication in individuals with dementia. World Journal of Psychiatry 12:2, pages 306-316.
Crossref
Peter Phiri, Tomas Engelthaler, Hannah Carr, Gayathri Delanerolle, Clive Holmes & Shanaya Rathod. (2022) Associated mortality risk of atypical antipsychotic medication in individuals with dementia. World Journal of Psychiatry 12:2, pages 298-307.
Crossref
Pedro Cabral Barata, Mário João Santos, João Carlos Melo & Teresa Maia. (2019) Olanzapine-Induced Hyperprolactinemia: Two Case Reports. Frontiers in Pharmacology 10.
Crossref
Luis G. Sobrinho & Nelson D. Horseman. (2019) Prolactin and human weight disturbances: A puzzling and neglected association. Reviews in Endocrine and Metabolic Disorders 20:2, pages 197-206.
Crossref